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Introduction: Studies indicate that women who have sex with women (WSW) report greater 
levels of drug use than heterosexual women, but globally few studies have looked at 
sexualised drug use among WSW. This study investigated the factors associated with drug 
use and sexualised drug use (SDU) among WSW. 
Methods: Potential participants across the UK were invited to take part in a cross-sectional 
anonymous online survey between April-June 2018. The LGBT Sex and Lifestyles survey 
recruited participants through Facebook advertising and social media posts from community 
organisations. Multivariate logistic regression was used to compare WSW who had engaged 
in any drug use in the past 12 months with those who had not, and those who engaged in 
sexualised drug use in the past 12 months with those who engaged in other drug use. 
Results: 1,501 WSW could be included in the analyses (mean age=28.9, 97% white 
ethnicity). Any drug use was reported by 39% of WSW (n=583), 44% of which (17% of total, 
n=258) reported SDU. Factors associated with drug use were identifying as queer (aOR=1.86, 
95%CI 1.08, 3.23), younger age (aOR=0.96, 95%CI 0.95, 0.98), being born outside the UK 
(aOR=1.75, 95%CI 1.15, 2.66), recent sexual assault (aOR=2.35, 95%CI 1.43, 3.86), >=5 
female sexual partners (aOR=3.81, 95%CI 1.81, 8.01), and psychological distress 
(aOR=1.75, 95%CI 1.15, 2.67). SDU was associated with identifying as bisexual (aOR=2.55, 
95%CI 1.69, 3.86), >=5 female sexual partners (aOR=4.50, 95%CI 1.91, 10.59), and highest 
education achieved at 16 or lower (aOR=2.46, 95%CI 1.24, 4.90).  
Conclusions: Some WSW may have negative experiences in relation to drug use and SDU. 
Harm reduction and health services that provide services for WSW should be aware of 
potentially compounding factors related to drug use, such as sexual assault and psychological 
distress, providing a safe and LGBT-friendly environment to discuss these issues. 
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In Europe, North America, and Australasia, lesbian, gay and bisexual (LGB) people 
report higher rates of substance use and mental health conditions compared to heterosexual 
people (King et al., 2008). In the UK, a national survey found that gay and bisexual women 
were more likely to report engaging in illicit drug use in comparison to heterosexual women 
(23% vs. 5%)(ONS, 2014). Young adults in the UK who identify as gay, lesbian or bisexual 
have reported more binge drinking, solvent use, cannabis and other drug use compared to 
heterosexual young adults, and those who identified as bisexual were more likely to report 
worse physical functioning, health satisfaction, and overall life satisfaction (Booker, Rieger, 
& Unger, 2017). However, data were not available by gender and specific to women who 
have sex with women (WSW). Among lesbian, bisexual and queer women in Australia, 
women who identified as queer or bisexual reported a higher proportion of recent illicit drug 
use, and higher proportions of sexual coercion since 16 years old compared to women who 
identified as lesbian/gay (Germanos, Deacon, & Mooney-Somers, 2015). 
Studies on drug use among LGBT people have often focused on men who have sex 
with men (MSM), with much of this research into alcohol and drug use related to substances 
used in a sexual and/or party context (Bourne & Weatherburn, 2017). Most recently, research 
has focused on the rise of chemsex as a public health issue (Stuart, 2013). Chemsex 
(sometimes referred to as ‘party and play’) is a particular form of sexualised drug use among 
MSM that involves men engaging in sex with other men for long periods of time, with 
multiple partners, and taking crystal methamphetamine, γ-hydroxybutyrate/ γ-butyrolactone 
(GHB/GBL), mephedrone, cocaine and/or ketamine immediately before or during sex 
(Bourne, Reid, Hickson, Torres Rueda, & Weatherburn, 2014). However, both sexualised 
drug use and chemsex are not exclusively observed among MSM (Mohammed et al., 2016). 
A UK survey of people who inject drugs found that WSW were more likely than heterosexual 
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women to report use of those drugs associated with chemsex among MSM, such as non-
injected mephedrone and non-injected ketamine use, however, it was not asked if this was 
sexualised drug use (Heinsbroek, Glass, Edmundson, Hope, & Desai, 2018). In Australia, 
sexualised drug use has been observed among WSW, with 8% of those using 
methamphetamine, 9% of those using ecstasy, and 10% of those using cocaine having taken 
these drugs before or during sex (Mooney-Somers, Deacon, Scott, Price, & Parkhill, 2018). 
The focus on MSM and sexualised drug use/chemsex is appropriate considering the 
associated sexual risks (Bourne et al., 2014; Glynn et al., 2018; Hegazi et al., 2017), but little 
is known about drug use and sexualised drug use among WSW, and the effect this may have 
on physical and mental wellbeing (Desai, Bourne, Hope, & Halkitis, 2018). A study in the 
USA found that women who identify as heterosexual but have had a recent female partner 
were more likely to binge drink, use cannabis and cocaine, and more likely to engage in sex 
with a man while under the influence of cannabis or cocaine compared to exclusively 
heterosexual women (Bauer, Jairam, & Baidoobonso, 2010). Among women attending a 
sexual health clinic in Chicago, lesbian women had a greater odds of alcohol and drug use in 
the past 12 months. However, when controlling for age and race, bisexual women had greater 
odds of drug use at last sex act compared to heterosexual women (Estrich, Gratzer, & Hotton, 
2014). Research among lesbian, gay and bisexual youth found reporting a greater number of 
sexual partners was associated with cannabis use, however, drug use was not specified to be 
during sex, and data were not available specific to WSW (Zhang & Wu, 2017).  
Internalised homophobia and discrimination based on sexuality can impact on 
behaviours leading to increased risk and poor health outcomes (Meyer, 2003). However, the 
association between substance use and discrimination or internalised homophobia is unclear, 
with some studies having found associations among LGB women (Lehavot & Simoni, 2011), 
whilst another study found that the use cocaine, crystal methamphetamine, GHB, ketamine or 
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speed among LGB men and women was not associated with discrimination or greater 
internalised homophobia (Lea, de Wit, & Reynolds, 2014). Qualitative interviews with gay 
men engaging in chemsex found that internalised homophobia and the intense sexual 
experience of chemsex were motivations for engagement (Weatherburn, Hickson, Reid, 
Torres-Rueda, & Bourne, 2017). 
 Very little research exists internationally regarding sexualised drug use among WSW, 
and therefore the extent, nature and factors associated with this are not understood. This 
research aims to investigate drug use and sexualised drug use among WSW in the UK, 
comparing psychosocial and sexual factors among WSW who have not engaged in any drug 
use with those that have engaged in drug use, and those that have engaged in sexualised drug 
use with those that have engaged in drug use. 
Methods 
The LGBT Sex and Lifestyles Survey was a cross-sectional online questionnaire 
aimed at LGBT people in the UK. Ethical approval for this study was obtained from the 
LJMU Research Ethics Committee. A convenience sample was obtained using sponsored 
Facebook advertising and advertisments on social media via relevant LGBT organisations. 
Four LGBT organisations promoted the survey on their social media accounts and four 
sponsored adverts were run on Facebook for 6 weeks between April and June 2018, targeting 
MSM, WSW, trans people, or LGBT people generally. Facebook users were shown the 
sponsored advert for the “Sex and Lifestyles Survey” if they engaged with one or more 
MSM, WSW, trans or LGBT topics on Facebook. Participants were invited to take part in the 
survey if they had ever had a sexual partner of the same gender and/or they identified as 
trans. Participants were then directed to the online survey, and asked two screening questions, 
stating that they were aged 18 or over, and currently living in the UK. To aid recruitment 
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participants were offered entry into a prize draw to win a £50 Amazon voucher, or one of two 
£25 Amazon vouchers. 
Measures 
The questionnaire was divided into three areas: demographics, sexual health and drug 
use, and psychological wellbeing. Participants were categorised as WSW if they identified as 
female and stated they had sex with women. There were five answer options for sexual 
identity (lesbian/homosexual; bisexual; queer; in another way, please specify; or prefer not to 
say). Sexual health questions were adapted from research on similar topics (Mercer et al., 
2016; Weatherburn et al., 2013). Questions that were adapted for use with WSW were those 
on the number of sexual partners, condom use (if having sex with men), and on health service 
use. Aligned with previous research, drug use and sexualised drug use was asked with regards 
to specific drugs and individual drugs were listed rather than grouped, as this is likely to elicit 
more accurate reporting (Ryan et al., 2018). Participants were first asked if they had taken 
any of the 14 listed substances in the past 12 months. Sexualised drug use was grouped as 
participants who had stated they had been under the influence of cannabis during sex in the 
past 12 months or stated having taken amphetamine, cocaine, crack cocaine, ecstasy, heroin, 
GHB/GBL, ketamine, mephedrone, methamphetamine, Viagra or other erectile dysfunction 
drug, poppers, or another unspecified drug just before or during sex in the past 12 months. A 
further grouping was created for the drugs associated with chemsex, which included those 
reporting the use GHB/GBL, ketamine, mephedrone and/or methamphetamine just before or 
during sex. Chemsex drugs were looked at separately to allow comparison with the extent of 
their use within other groups, and because of the risk associated with use GHB/GBL, 
ketamine, and methamphetamine, such as, overdose and loss of consciousness. Questions 
regarding motivations for engaging in sexualised drug use and sex under the influence of 
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alcohol were adapted from motivations and attitudes towards chemsex questions (Glynn et 
al., 2018).  
A question that has been used in a primary care setting was used to assess whether 
participants had experienced any sexual contact that was not consensual (Coxell, King, 
Mezey, & Gordon, 1999). This was adapted after a discussion with an LGBT sexual violence 
charity to the following: “In the past 12 months has a person(s) done sexual things to you or 
made you do sexual things without your consent?” Participants could respond “Yes”, “No”, 
“Not sure” or “Prefer not to say”. 
Psychological wellbeing was measured using a variety of previously validated scales. 
The Internalised Homophobia scale (Herek, Cogan, Gillis, & Glunt, 1998) was used to 
measure internalised stigma among WSW (Cronbach’s alpha=0.86). In line with the 
categorisation used in the scale development, if a participant responded strongly disagree or 
disagree to any question they were categorised as having high internalised homophobia. 
Discrimination based on sexuality was measured within the past 12 months across a number 
of settings, and was categorised as any discrimination based on sexuality in the past 12 
months (Burgess, Tran, Lee, & van Ryn, 2007). The Objectified Body Consciousness scale 
(Hyde & McKinley, 2006) was used to measure body image satisfaction, where higher scores 
indicated greater body dissatisfaction (Cronbach’s alpha=0.90). A 3-item loneliness scale 
developed for use in long questionnaires was used (Hughes, Waite, Hawkley, & Cacioppo, 
2004), where higher scores indicated higher feelings of loneliness (Cronbach’s alpha=0.82). 
The Satisfaction With Life Scale (SWLS; Diener, Emmons, Larsen, & Griffin, 1985) 
measured life satisfaction, with higher scores indicating higher life satisfaction (Cronbach’s 
alpha=0.90). The Kessler Psychological Distress Scale (Andrews & Slade, 2001) was used to 
measure psychological distress (Cronbach’s alpha=0.94), and scores were categorised into 
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normal (<=15), moderate (16-21), high (22-29) and very high (30-50), as in previous research 
(Stallman, McDermott, Beckmann, Kay Wilson, & Adam, 2010).  
Statistical Analysis  
 The varaibles included in the analyses were demographics, sexual behaviours and 
psychological factors such as internalised homophobia, experiences of discrimination and 
psychologcial distress. These were chosen to reflect factors associated with drug use among 
LGBT people in previous studies. We also postulated that sexualised drug use might be 
assocaited with population density, as previous studies of MSM indicate that sexualised drug 
use may be more common among urban poluations (Hibbert, Brett, Porcellato, & Hope, 
2019). All analyses were conducted using SPSS 25. Forward stepwise multivariate logistic 
regression analyses were used to explore factors associated with engaging in drug use 
compared to not engaging in drug use, and factors associated with engaging in sexualised 
drug use as opposed to drug use (entry p=0.05, removal p=0.10). Factors approaching 
significant at the univariate level (p<0.10) were included in the multivariate model. 
Descriptive chi-square and Fisher-exact test analyses were used to compare motivations for 
and effects of engaging in, intentional sexualised drug use, sex under the influence of 
cannabis, and sex under the influence of alcohol. 
Results 
Of the 4,690 surveys started, 53 participants were excluded for not living in the UK, 
43 participants were excluded for being under 18, and 1,014 did not complete the survey 
sufficiently to be included in analyses (completion rate of 78%). The median time taken to 
complete the survey was 12 minutes. Of the 3,676 participants included, 1,513 participants 
were identified as WSW, and 1,506 WSW completed the drug use and sex questions to be 
included in the analysis. Five WSW identified as heterosexual and were not included in the 
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analysis. WSW who completed the survey were more likely to be in a relationship than those 
who did not (72% vs. 59%, p<0.01), but did not differ on any other demographic variables 
where data were avaliable. Over half of the 1,501 WSW identified as homosexual/gay/lesbian 
(56%), 97% were of white ethnicity, 29% were single/not in a relationship, the mean age was 
28.9 (SD = 9.4, range 18-73), and two thirds reported high or very high levels of 
psychological distress. Seven percent of WSW reported sexual contact without consent in the 
past 12 months, the majority of which identified as bisexual (56%, p<0.001). 
The majority of participants had drank alcohol in the past 12 months (94%), and 67% 
of these (63% of total sample) had engaged in sex under the influence of alcohol. Figure 1 
displays data regarding prevalance of drugs taken and sexualised drug use among WSW. 
Because no WSW reported taking crystal methamphetamine, it was not included in the 
chemsex drug group. Overall, 39% of WSW reported taking a drug in the last 12 months, 
44% of these (17% of the total sample) reported engaging in sexualised drug use. Women 
reporting sexualised drug use were more likely to report having sex with both men and 
women, compared to women only (25% vs. 11%, p<0.001). The drug most commonly taken 
generally and sexually was cannabis (33% and 14% respectively). Over one-quarter of 
cocaine users (46/163) and one-fifth of ecstacy users (24/113) reported taking the drug just 
before or during sex. The most commonly used drug associated with chemsex was ketamine 
(n=36, 2%), followed by mephedrone (n=6, 0.4%) and GHB/GBL (n=3, 0.2%). Of those who 
had taken a chemsex related drug, 22% (n=9/41) reported taking that drug just before or 
during sex. Of the nine WSW who reported sexualised use of a chemsex related drug, seven 
reported having sex with both men and women. 
Table 1 displays the univariate and multivariate analyses for the psychosocial and 
sexual factors associated with engaging in drug use compared to no drug use. Due to the 
strong association between psychological wellbeing measures, only psychological distress 
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was included in the multivariate analyses due to this measuring recent feelings of distress 
(past 30 days). The factors associated with engaging in drug use with the highest odds ratios 
were having greater than or equal to 5 women sexual partners in the past 12 months, and 
experiencing sexual contact without consent in the past 12 months. Other factors associated 
with engaging in drug use were identifying as queer, having a country of birth outside of the 
UK, living in more densly populated areas, having 2-4 women sexual partners in the past 12 
months, and having high or very high levels of psychological distress. Increases in age was 
associated with a reduced liklihood of reported drug use. 
These analyses were repeated to examine factors associated with sexualised drug use 
compared to drug use (Table 2). Factors that were associated of sexualised drug use were 
identifying as bisexual or in another way, highest level of education qualifications at age 16 
or lower, and having 2 or more sexual partners in the past 12 months. Being single was 
associated with reduced likelihood of engaging in sexualised drug use. 
Figure 2 compares the motivations for and effects of intentional sexualised drug use, 
sex under the influence of cannabis, and sex under the influence of alcohol. WSW who 
reported intentional sexualised drug use were more likely to report doing so because it gives 
an intense sexual experience and allows them to have sex for longer. WSW who reported 
engaging in sexualised drug use and those who reported engaging in sex under the influence 
of alcohol were more likely to report doing things they would not do sober.  
 






Table 1. Univariate and multivariate analysis for factors associated with drug use in the past 12 months among WSW. 
 No drugs taken (n=918) Taken drugs (n=583) Univariate Adjusted model 
 n or mean % or SD n or mean % or SD Row % OR (95% CI) aOR (95% CI) 
Sexuality        
Lesbian/homosexual 550 60% 297 51% 35% ref. ref. 
Bisexual 276 30% 217 37% 44% 1.46 (1.16, 1.83) 1.17 (0.90, 1.53) 
Queer 35 4% 45 8% 56% 2.38 (1.50, 3.79) 1.86 (1.08, 3.23) 
In another way 57 6% 24 4% 30% 0.78 (0.47, 1.28) 0.57 (0.32, 1.03) 
Age 30.6 10.0 26.4 7.8  0.95 (0.94, 0.96) 0.96 (0.95, 0.98) 
Ethnicity        
White 897 98% 560 96% 38% ref.  
Person of colour 20 2% 23 4% 53% 1.84 (1.00, 3.39)  
Country of Birth       
UK 829 90% 509 87% 38% ref. ref. 
Not UK 67 7% 61 10% 48% 1.48 (1.03, 2.13) 1.75 (1.15, 2.66) 
Education       
University or higher 517 56% 298 51% 37% ref.  
Qualifications at 18 280 31% 226 39% 45% 1.40 (1.12, 1.76)  
Qualifications at 16 or lower 96 10% 50 9% 34% 0.90 (0.62, 1.31)  
Work Status       
Full time 526 57% 249 43% 32% ref.  
Part time 108 12% 67 11% 38% 1.31 (0.93, 1.84)  
Student 152 17% 181 31% 54% 2.52 (1.93, 3.27)  
Unemployed 23 3% 16 3% 41% 1.47 (0.76, 2.83)  
Other (sick leave, retired, carer) 96 10% 66 11% 41% 1.45 (1.03, 2.06)  
Relationship status       
Living with partner 433 47% 193 33% 31% ref.  
Relationship not living with partner 228 25% 170 29% 43% 1.67 (1.29, 2.17)  
Relationship with multiple 25 3% 19 3% 43% 1.71 (0.92, 3.17)  
Single 231 25% 201 34% 47% 1.95 (1.51, 2.52)  
Population density per hectare      
<5 244 27% 142 25% 37% ref. ref. 
5 - 20  283 31% 150 26% 35% 0.91 (0.68, 1.21) 0.90 (0.65, 1.25) 
20 - 41  220 24% 145 25% 40% 1.13 (0.84, 1.52) 1.12 (0.81, 1.57) 
>41  162 18% 140 24% 46% 1.49 (1.09, 2.02) 1.47 (1.04, 2.10) 
Internalized homophobia      
Low 636 69% 355 61% 36% ref.  
High 259 28% 221 38% 46% 1.53 (1.23, 1.91)  
Discrimination sexuality in the past 12 months     
None 486 53% 273 47% 36% ref.  
Any setting 406 44% 288 49% 41% 1.26 (1.02, 1.56)  
Sexual contact without consent in the past 12 months    
No  861 94% 488 84% 36% ref. ref. 
Yes 31 3% 70 12% 69% 3.98 (2.57, 6.17) 2.35 (1.43, 3.86) 
Unsure 14 2% 17 3% 55% 2.14 (1.05, 4.38) 1.45 (0.59, 3.58) 
Number of women sexual partners in the past 12 months    
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0-1 774 85% 415 71% 35% ref. ref. 
2-4 129 14% 136 23% 51% 1.97 (1.50, 2.57) 1.81 (1.33, 2.43) 
>=5 13 1% 32 5% 71% 4.59 (2.38, 8.84) 3.81 (1.81, 8.01) 
Perceived health       
Fair/good/very good 779 85% 462 79% 37% ref.  
Very poor/poor 139 15% 121 21% 47% 1.47 (1.12, 1.92)  
Psychological distress       
Normal 149 16% 48 8% 24% ref. ref. 
Moderate 200 22% 93 16% 32% 1.44 (0.96, 2.17) 1.17 (0.74, 1.85) 
High 226 25% 145 25% 39% 1.99 (1.35, 2.93) 1.66 (1.07, 2.56) 
Very high 334 36% 289 50% 46% 2.69 (1.87, 3.86) 1.75 (1.15, 2.67) 
Body satisfaction 41.3 13.3 43.9 12.1  1.02 (1.01, 1.02)  
Loneliness score 5.3 1.7 5.8 1.8  1.20 (1.13, 1.28)  




Table 2. Univariate and multivariate analyses for factors associated with sexualised drug use in the past 12 months compared to drug use among WSW. 
 Taken drugs (n=323) Sexualised drug use (n=260) Univariate Adjusted model 
 n or mean % or SD n or mean % or SD Row % OR (95% CI) aOR (95% CI) 
Sexuality        
Lesbian/homosexual 188 58% 109 42% 37% ref. ref. 
Bisexual 101 31% 116 45% 53% 1.98 (1.39, 2.83) 2.55 (1.69, 3.86) 
Queer 25 8% 20 8% 44% 1.38 (0.73, 2.60) 1.30 (0.64, 2.67) 
In another way 9 3% 15 6% 63% 2.88 (1.22, 6.79) 3.17 (1.22, 8.21) 
Age 26.7 8.0 25.9 7.5  0.99 (0.97, 1.01)  
Ethnicity        
White 311 96% 249 96% 44% ref.  
Person of colour 12 4% 11 4% 48% 1.15 (0.50, 2.64)  
Country of Birth       
UK 286 89% 223 86% 44% ref.  
Not UK 30 9% 31 12% 51% 1.33 (0.78, 2.26)   
Education       
University or higher 174 54% 124 48% 42% ref. ref. 
Qualifications at 18 124 38% 102 39% 45% 1.15 (0.81, 1.64) 1.13 (0.76, 1.68) 
Qualifications at 16 or lower 19 6% 31 12% 62% 2.29 (1.24, 4.24) 2.46 (1.24, 4.90) 
Work Status       
Full time 149 46% 100 38% 40% ref.  
Part time 37 11% 30 12% 45% 1.21 (0.70, 2.08)  
Student 99 31% 82 32% 45% 1.23 (0.84, 1.82)   
Unemployed 7 2% 9 3% 56% 1.92 (0.69, 5.31)  
Other (sick leave, retired, carer) 29 9% 37 14% 56% 1.90 (1.10, 3.29)  
Relationship status       
Living with partner 107 33% 86 33% 45% ref. ref. 
Relationship not living with partner 82 25% 88 34% 52% 1.34 (0.88, 2.02) 0.75 (0.46, 1.20) 
Relationship with multiple 6 2% 13 5% 68% 2.70 (0.98, 7.39) 1.00 (0.30, 3.30) 
Single 128 40% 73 28% 36% 0.71 (0.47, 1.06) 0.31 (0.18, 0.52) 
Population density per hectare      
<5 77 24% 65 25% 46% ref.  
5 - 20  87 27% 63 24% 42% 0.86 (0.54, 1.36)  
20 - 41  80 25% 65 25% 45% 0.96 (0.61, 1.53)  
>41  77 24% 63 24% 45% 0.97 (0.61, 1.55)  
Internalized homophobia      
Low 197 61% 158 61% 45% ref.  
High 122 38% 99 38% 45% 1.01 (0.72, 1.42)  
Discrimination sexuality in the past 12 months    
None 158 49% 115 44% 42% ref.  
Any setting 153 47% 135 52% 47% 1.21 (0.87, 1.69)  
Sexual contact without consent in the past 12 months   
No 280 87% 208 80% 43% ref.  
Yes 31 10% 39 15% 56% 1.69 (1.02, 2.81)  
Unsure 9 3% 8 3% 47% 1.20 (0.45, 3.15)  
Number of women sexual partners in the past 12 months   
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0-1 250 77% 165 63% 40% ref. ref. 
2-4 61 19% 75 29% 55% 1.86 (1.26, 2.75) 2.96 (1.83, 4.79) 
>=5 12 4% 20 8% 63% 2.53 (1.20, 5.30) 4.50 (1.91, 10.59) 
Perceived health       
Fair/good/very good 263 81% 199 77% 43% ref.  
Very poor/poor 60 19% 61 23% 50% 1.34 (0.90, 2.01)  
Psychological distress      
Normal 31 10% 17 7% 35% ref. ref. 
Moderate 61 19% 32 12% 34% 0.96 (0.46, 1.99) 0.79 (0.36, 1.72) 
High 89 28% 56 22% 39% 1.15 (0.58, 2.26) 1.14 (0.55, 2.39) 
Very high 135 42% 154 59% 53% 2.08 (1.10, 3.93) 1.77 (0.88, 3.59) 
Body satisfaction 42.7 12.6 45.6 11.3  1.02 (1.01, 1.03)  
Loneliness score 5.7 1.8 6.0 1.8  1.10 (1.01, 1.21)  








 The aim of this research was to investigate drug use and sexualised drug use among 
WSW, and found variation in the types of drugs and sexualised drugs used, which has not 
previously been investigated. Sexualised drug use was common among WSW when 
considering the use of a wide range of drugs in a sexual context, and the most common drug 
used was cannabis. Higher levels of ecstasy and cocaine use for sex were observed in this 
sample when compared to research among Australian LBQ women (Mooney-Somers et al., 
2018), however no women in the current research reported taking methamphetamine, 
regardless of whether it was for sexual purposes. When considering intentional sexualised 
drug use, reported motivations for engaging in this were similar to those reported among 
MSM, such as giving an intense sexual experience and having sex for longer (Weatherburn et 
al., 2017). Similar to previous research, the use of drugs associated with chemsex was 
reported among WSW (Heinsbroek et al., 2018), and we found evidence that these drugs 
were sometimes being used in a sexual context among WSW, albeit by a very small 
proportion (<1%), particularly when compared to MSM, one in 17 of whom report sexualised 
use of chemsex associated drugs (Hibbert et al., 2019).  
 Overall, 7% of participants reported experiencing sexual assault, and this was 
associated with drug use. This could be that drug use is a coping mechanism used by WSW 
who experience sexual assault, or that WSW who engage in drug use are more likely to 
experience sexual assault, as they may be more vulnerable when under the influence of drugs.  
In univariate analyses, WSW engaging in sexualised drug use were more likely to report 
experiencing sexual assault compared to those engaging in non-sexualised drug use, but this 
was not significant in multivariate analyses, possibly because the majority of women 
experiencing sexual assault were bisexual, similar to previous research (Germanos et al., 
2015). It is not clear whether the sexual assault related to male or female partners, and due to 
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the sensitive nature of the topic, it is ethically challenging to collect event-level detail 
regarding sexual assault. A broad measure of sexual assault was used in our study as diverse 
populations were being recruited into the LGBT Sex and Lifestyles Survey and to avoid a 
focus on penetrative assault, which limits our exploration of the nature of these assaults. 
Future research is needed to fully understand this association between drug use and sexual 
assault, and support services need to be available for WSW who experience sexual assault. 
 Engaging in drug use was associated with an increasing number of recent female 
sexual partners, and engaging in sexualised drug use was further associated with the number 
of recent female sexual partners. Sexualised drug use was mostly under the influence of 
cannabis, which reflects previous research among LGB youth that found an association 
between cannabis use and number of sexual partners (Zhang & Wu, 2017). However, the 
current research found this association specifically among WSW and when measuring drug 
use in a sexual context.  
Discrimination and internalised homophobia were associated with drug use in 
univariate analyses, which is similar to previous research (Lehavot & Simoni, 2011). 
However, possibly due to the association between these issues and psychological distress, this 
effect was not observed in the multivariate analysis. Discrimination and internalised 
homophobia were not associated with sexualised drug use among those taking drugs in this 
study.  
Similar to previous research, identifying as queer was found to be associated with 
drug use (Germanos et al., 2015). Previous research has also found that bisexual men and 
women were more likely to engage in drug use (Booker et al., 2017). The current study did 
not find such an association between drug use overall identifying as bisexual, but WSW 
identifying as bisexual were more likely to report sexualised drug use compared to general 
18 
 
drug use in the multivariate analysis. Similarly, research has previously found that bisexual 
women were more likely to have reported sex under the influence of drugs with a man 
compared to heterosexual women (Bauer et al., 2010; Estrich et al., 2014). Due to the 
exploratory nature of this study and the need to have a concise questionnaire for ease of 
completion, limited event-level data was collected for WSW reporting sexualised drug use, 
and so we are unable to further explore risk. The impact of sexualised drug use on WSW 
sexual health will be dependent upon the gender of their sexual partner and the type of sex 
they were having. Therefore, future research on this topic should seek to gain event-level 
data, such as partner’s gender and details of sexual practices.  
Heterosexual identifying WSW were excluded from this study due to small numbers. 
However, previous research has found heterosexual identifying WSW were more likely to 
engage in drug use and sexualised drug use (Bauer et al., 2010). The small number of 
participants in this group is probably reflective of the Facebook advertising used to recruit 
participants, as people had to engage with LGBT content on Facebook to be shown the 
advert, which heterosexual identifying WSW may be less likely to do. Future studies should 
consider the use of other recruitment approaches to reach more heterosexual identifying 
WSW, and sexual health clinics may have a role to play due to their focus on collecting 
sexual history rather than identity. Similarly, the vast majority of participants were white, 
which could reflect the limitations of social media for recruitment. Whilst a higher proportion 
of WSW of colour engaged in drug use, this was not significant. Representation from LGBT 
people of colour has been noted as an issue in other UK-based LGBT research (McNeil, 
Bailey, Ellis, Morton, & Regan, 2012). Future research should aim to be more reflective of 
WSW of colour to investigate this further, and reflect the lives and experiences of all WSW. 
Despite the slightly young age of the sample, again probably due to using Facebook for 
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recruitment, being of a younger age was still associated with drug use among WSW, similar 
to previous research (Booker et al., 2017).  
As noted above our study has a number of limitations. There is limited data on the 
size and nature of the LGBT population in the UK, so it is difficult assess the 
representativeness of the sample. The LGBT Sex and Lifestyles Survey sample when 
compared to the UK general population, under represents some ethnic minorities and older 
people. However, online surveys are a well-established approach for sampling from LGBT 
populations in the UK and other higher income countries. Our sampling approach which used 
a social networking site and community organisations, may be more robust than those used in 
many other studies which have focus on recruitment through geospatial dating apps, as those 
in mutually exclusive relationships are probably less likely to use these apps. Finally, our 
study relied on self-report measures, though where possible standardised tools and questions 
were used, responses may still be subject to recall bias.  
In conclusion, WSW may have a range negative experiences in relation to drug use 
and sexualised drug use, specifically greater psychological distress and experiences of sexual 
assault. Mental health services in the UK should be aware of potentially compounding issues 
among WSW engaging in drug use and sexualised drug use. Due to the lack of research 
around drug use and especially sexualised drug use among WSW globally, we recommend 
that future drug research be inclusive of WSW to explore these experiences further, including 
the role of sexual identity and attempt to find if there are any causal associations. 
Additionally, the sexual health implications of sexualised drug use among WSW should be 
assessed by collecting event-level data regarding the partner’s gender and the specific sexual 
behaviours. Research in this area tends to describe itself as LGBT but does not usually 
represent all LGBT people, or where all LGBT people are included, data are not available by 
gender. Health services that come into contact with WSW such as sexual health clinics, drug 
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and alcohol centres, and counselling services, should be aware of potentially compounding 
factors related to drug use among WSW, such as sexual assault and psychological distress, 
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